Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals Ltd

₹ 1,391 -0.06%
08 Aug - close price
About

Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]

Key Points

Hospital Portfolio[1][2]
The company operates 3 hospitals with 1,275 Doctors across:
a) Thane - 377 Operating Beds and 72.1% Average Occupancy
b) Pune - 309 Operating Beds and 54.9% Average Occupancy
c) Indore - 375 Operating Beds and 65.5% Average Occupancy

  • Market Cap 9,121 Cr.
  • Current Price 1,391
  • High / Low 1,770 / 1,250
  • Stock P/E 47.4
  • Book Value 207
  • Dividend Yield 0.07 %
  • ROCE 18.0 %
  • ROE 15.0 %
  • Face Value 10.0

Pros

  • Company has delivered good profit growth of 43.6% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
201 221 228 242 243 263 273 291 289 323 322 327 348
151 166 183 191 190 202 211 228 223 248 246 248 270
Operating Profit 49 55 45 52 53 61 62 63 65 75 76 78 78
OPM % 25% 25% 20% 21% 22% 23% 23% 22% 23% 23% 24% 24% 22%
2 3 2 1 4 3 8 10 7 9 7 7 13
Interest 10 10 11 11 12 12 1 1 1 1 3 6 8
Depreciation 9 10 10 10 11 11 11 10 11 14 14 18 21
Profit before tax 32 38 27 32 34 41 58 62 60 69 67 62 62
Tax % 5% 29% 101% 51% -60% 19% 25% 27% 26% 25% 21% 28% 29%
30 27 -0 16 54 34 44 45 45 52 53 45 44
EPS in Rs 5.99 5.32 -0.07 2.79 9.55 5.14 6.66 6.87 6.78 7.86 7.99 6.84 6.69
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
463 486 733 893 1,073 1,262 1,319
379 419 580 691 831 965 1,011
Operating Profit 84 67 153 201 242 297 308
OPM % 18% 14% 21% 23% 23% 24% 23%
0 4 4 8 22 29 36
Interest 26 39 44 42 26 11 18
Depreciation 26 31 36 39 42 57 67
Profit before tax 33 2 77 129 195 258 259
Tax % 10% 248% 34% 43% 10% 25%
30 -2 51 73 177 194 193
EPS in Rs 5.83 -0.45 10.05 12.90 26.94 29.51 29.38
Dividend Payout % 0% 0% 0% 0% 4% 3%
Compounded Sales Growth
10 Years: %
5 Years: 22%
3 Years: 20%
TTM: 18%
Compounded Profit Growth
10 Years: %
5 Years: 44%
3 Years: 55%
TTM: 16%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 4%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 19%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 51 51 51 57 66 66
Reserves 186 188 243 309 1,103 1,291
272 426 495 469 0 393
94 124 120 151 112 155
Total Liabilities 603 789 909 986 1,281 1,905
435 630 684 720 718 977
CWIP 10 26 27 29 74 185
Investments 2 7 3 2 17 114
156 126 195 235 473 628
Total Assets 603 789 909 986 1,281 1,905

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
74 123 137 117 115 253
-43 -295 -84 -104 -246 -209
-32 184 32 18 128 301
Net Cash Flow -1 12 85 31 -3 345

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 35 16 14 19 19 12
Inventory Days 64 48 39 44 41 38
Days Payable 268 217 157 164 120 163
Cash Conversion Cycle -169 -152 -104 -101 -59 -113
Working Capital Days 17 -7 -24 -24 -5 -20
ROCE % 7% 17% 21% 22% 18%

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91%
4.62% 3.96% 4.17% 6.06% 8.84% 10.04% 10.04% 9.77%
12.69% 13.92% 14.16% 13.85% 13.46% 15.75% 15.64% 15.82%
41.80% 41.19% 40.76% 39.18% 36.79% 33.31% 33.43% 33.51%
No. of Shareholders 54,78239,34835,10735,79734,08133,91433,95634,192

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls